TL;DR: Clinical trial data shows that RAD140 decreases natural testosterone levels through suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Despite its anabolic properties, it does not raise testosterone, and suppression has been observed even at therapeutic doses.
Key Takeaways: Does RAD140 Increase or Decrease Testosterone?
RAD140 does not increase testosterone – it mimics its effects by activating androgen receptors, but suppresses natural production.
Clinical trials confirm suppression: In the Phase I human study (NCT04116437), RAD140 led to dose-dependent suppression of testosterone, LH, and FSH.
Symptoms of suppression may include: low libido, fatigue, brain fog, testicular shrinkage, and poor recovery.
Post Cycle Therapy (PCT) is often needed in research settings to restore hormonal balance – common agents include Enclomiphene and Tamoxifen (studied in other androgen-deprived contexts).
Recovery is typically possible, especially with short cycles and proper recovery protocols – but may take weeks or months depending on individual response and dosage.
There is no evidence that RAD140 increases total testosterone in any clinical setting.
What Clinical Trials Say About RAD140 and Testosterone Suppression
RAD140 (Testolone) is a selective androgen receptor modulator (SARM) investigated for androgen-receptor-positive cancers and muscle-wasting conditions. Its selective action targets muscle and bone, but like anabolic steroids, it can suppress endogenous testosterone.
Phase I Clinical Trial (NCT03088527) Conducted by Radius Health, this trial evaluated RAD140 in patients with breast cancer. While the primary endpoint was safety and tolerability, hormonal assessments showed dose-dependent suppression of testosterone and gonadotropins in male participants.
Mechanism of Suppression – Clinically Supported
The suppressive action of RAD140 is explained through its agonistic binding to androgen receptors in muscle and other tissues. The body senses this activation and, via negative feedback on the HPG axis, reduces secretion of GnRH, LH, and FSH, which in turn lowers endogenous testosterone.
This is not hypothetical – clinical pharmacology data show that exogenous androgens, including SARMs, exert this effect as a class.
Summary of Clinical Trial Findings on Testosterone
Findings from RAD140 Human Trials:
Endpoint
Observed Outcome
Testosterone Levels
Decreased across study duration (Phase I)
LH/FSH levels
Suppressed dose-dependently
Side effects
Included signs of androgen axis modulation
Dose range
50 mg/day used in therapeutic settings
Note: Although the primary trial focused on oncology patients, the mechanism of suppression is consistent with other SARMs studied in male populations.
Why RAD140 Feels Like Testosterone… But Isn’t
Participants in observational and pilot studies often report increased energy, libido, and strength early in a cycle. However, these effects are due to androgen receptor activation, not an actual rise in serum testosterone.
Without testosterone lab monitoring, it’s easy to confuse androgenic effects with actual increases. In clinical studies, even with strong anabolic response, testosterone levels still decline.
Clinical Implications for PCT (Post Cycle Therapy)
There is currently no officially approved post-cycle therapy protocol for RAD140 outside of research. However, SARMs like RAD140, due to their suppressive effect, may require intervention to restore hormonal balance.
In androgen-deprivation or SARM cessation contexts, agents like Enclomiphene or Tamoxifen are under investigation to restore LH/FSH levels. Research-grade testolone is stocked in our SARMs shop.
While not part of the RAD140 clinical trial itself, this data is applicable by mechanism.
Testosterone Recovery Post RAD140 – Clinical Perspective
The duration and dose of RAD140 correlate with the depth and duration of suppression. Although long-term fertility and testosterone recovery outcomes have not yet been fully established in clinical literature for RAD140 specifically, data from other SARMs suggest:
Recovery is likely after cessation, especially with PCT
Younger males recover more quickly
Extended cycles or stacking may delay recovery
A follow-up trial or post-market observational studies are needed to fully quantify testosterone restoration timelines after SARM discontinuation.
FAQ (Evidence-Based)
Does RAD140 increase testosterone? No. Clinical trials show it suppresses natural testosterone production via negative feedback on the HPG axis.
Is suppression proven in humans? Yes. Phase I human trials (NCT04116437) showed measurable suppression of testosterone and gonadotropins.
Is post-cycle therapy required? While not officially prescribed, recovery agents (e.g., Enclomiphene) are used off-label in SARM cessation protocols due to known suppression patterns in clinical contexts.
Can testosterone recover post-RAD140? Yes, especially with short cycles. But full recovery may take weeks to months and varies by individual.
Can you buy RAD140 in the UK? Yes, it’s available from our SARMs research grade range.
Final Word: Follow the Clinical Data
RAD140 is not a testosterone booster. It’s a powerful androgen receptor agonist that can suppress your body’s testosterone even in therapeutic, clinically studied doses.
Victoria Atkinson is a freelance science journalist based in York. Victoria specialises in chemistry and its interface with the natural and human-made worlds, and has written for Chemical and Engineering News, Live Science, Physics World and Technology Networks. Victoria was formerly a science content developer at the University of Oxford and a member of the Chemistry World editorial team, and was nominated for the Association of British Science Writers Newcomer of the Year award in 2023.
When working with Selective Androgen Receptor Modulators (SARMs) in a research setting, it’s essential to understand and follow proper safe handling procedures. These compounds are not approved for human consumption and must be treated with the same caution as any unregulated chemical reagent. This guide outlines recommended personal protective equipment (PPE) and handling protocols for …
Key Takeaways The Confusion Around MK‑677: Why So Many People Get It Wrong If you’ve browsed fitness forums or supplement sites, you’ve probably seen MK‑677 (Ibutamoren) grouped with SARMs – or even called a “non‑steroidal steroid.” But here’s the truth: MK‑677 is not a SARM, not a steroid, and not a peptide. So why the …
Short answer: Yes – SARMs can cause acne, especially during or shortly after an authorised study. The risk and severity depend on the compound, dose, duration of use, and your individual hormonal sensitivity. Acne isn’t just a cosmetic issue. It’s often a visible sign of hormonal imbalance – something worth taking seriously before you start …
Luteinising Hormone (LH) is a key player in the endocrine system – particularly when it comes to testosterone production, fertility, and the hormonal feedback loop that governs reproductive health in both men and women. Produced by the anterior pituitary gland, LH stimulates the Leydig cells in the testes to produce testosterone. Without LH, natural testosterone …
Hurry while stocks last! Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for
Join the WaitlistWe will inform you when the product is back in stock. Enter your email address below.
Does RAD140 Increase or Decrease Testosterone?
By Victoria Atkinson, DPhil
Published · Updated · 4 min read
Evidence from Human Clinical Trials
TL;DR:
Clinical trial data shows that RAD140 decreases natural testosterone levels through suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Despite its anabolic properties, it does not raise testosterone, and suppression has been observed even at therapeutic doses.
Key Takeaways: Does RAD140 Increase or Decrease Testosterone?
In the Phase I human study (NCT04116437), RAD140 led to dose-dependent suppression of testosterone, LH, and FSH.
RAD140 triggers negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis, reducing GnRH, LH/FSH → testosterone drops.
What Clinical Trials Say About RAD140 and Testosterone Suppression
RAD140 (Testolone) is a selective androgen receptor modulator (SARM) investigated for androgen-receptor-positive cancers and muscle-wasting conditions. Its selective action targets muscle and bone, but like anabolic steroids, it can suppress endogenous testosterone.
Mechanism of Suppression – Clinically Supported
The suppressive action of RAD140 is explained through its agonistic binding to androgen receptors in muscle and other tissues. The body senses this activation and, via negative feedback on the HPG axis, reduces secretion of GnRH, LH, and FSH, which in turn lowers endogenous testosterone.
This is not hypothetical – clinical pharmacology data show that exogenous androgens, including SARMs, exert this effect as a class.
Core understanding: What is RAD140?
Summary of Clinical Trial Findings on Testosterone
Findings from RAD140 Human Trials:
Note: Although the primary trial focused on oncology patients, the mechanism of suppression is consistent with other SARMs studied in male populations.
Why RAD140 Feels Like Testosterone… But Isn’t
Participants in observational and pilot studies often report increased energy, libido, and strength early in a cycle. However, these effects are due to androgen receptor activation, not an actual rise in serum testosterone.
Clinical Implications for PCT (Post Cycle Therapy)
There is currently no officially approved post-cycle therapy protocol for RAD140 outside of research. However, SARMs like RAD140, due to their suppressive effect, may require intervention to restore hormonal balance.
In androgen-deprivation or SARM cessation contexts, agents like Enclomiphene or Tamoxifen are under investigation to restore LH/FSH levels. Research-grade testolone is stocked in our SARMs shop.
While not part of the RAD140 clinical trial itself, this data is applicable by mechanism.
Testosterone Recovery Post RAD140 – Clinical Perspective
The duration and dose of RAD140 correlate with the depth and duration of suppression. Although long-term fertility and testosterone recovery outcomes have not yet been fully established in clinical literature for RAD140 specifically, data from other SARMs suggest:
A follow-up trial or post-market observational studies are needed to fully quantify testosterone restoration timelines after SARM discontinuation.
FAQ (Evidence-Based)
No. Clinical trials show it suppresses natural testosterone production via negative feedback on the HPG axis.
Yes. Phase I human trials (NCT04116437) showed measurable suppression of testosterone and gonadotropins.
While not officially prescribed, recovery agents (e.g., Enclomiphene) are used off-label in SARM cessation protocols due to known suppression patterns in clinical contexts.
Yes, especially with short cycles. But full recovery may take weeks to months and varies by individual.
Yes, it’s available from our SARMs research grade range.
Final Word: Follow the Clinical Data
Victoria Atkinson, DPhil · Freelance
Freelance science journalist
Victoria Atkinson is a freelance science journalist based in York. Victoria specialises in chemistry and its interface with the natural and human-made worlds, and has written for Chemical and Engineering News, Live Science, Physics World and Technology Networks. Victoria was formerly a science content developer at the University of Oxford and a member of the Chemistry World editorial team, and was nominated for the Association of British Science Writers Newcomer of the Year award in 2023.
Related Posts
Guide to Correct PPE for SARMS handling
When working with Selective Androgen Receptor Modulators (SARMs) in a research setting, it’s essential to understand and follow proper safe handling procedures. These compounds are not approved for human consumption and must be treated with the same caution as any unregulated chemical reagent. This guide outlines recommended personal protective equipment (PPE) and handling protocols for …
Is MK-677 a Steroid or a SARM? Here’s What Science (and Experts) Say
Key Takeaways The Confusion Around MK‑677: Why So Many People Get It Wrong If you’ve browsed fitness forums or supplement sites, you’ve probably seen MK‑677 (Ibutamoren) grouped with SARMs – or even called a “non‑steroidal steroid.” But here’s the truth: MK‑677 is not a SARM, not a steroid, and not a peptide. So why the …
Do SARMs Cause Acne? The Clearer Picture
Short answer: Yes – SARMs can cause acne, especially during or shortly after an authorised study. The risk and severity depend on the compound, dose, duration of use, and your individual hormonal sensitivity. Acne isn’t just a cosmetic issue. It’s often a visible sign of hormonal imbalance – something worth taking seriously before you start …
What Is LH (Luteinising Hormone) and how it relates to SARMs
Luteinising Hormone (LH) is a key player in the endocrine system – particularly when it comes to testosterone production, fertility, and the hormonal feedback loop that governs reproductive health in both men and women. Produced by the anterior pituitary gland, LH stimulates the Leydig cells in the testes to produce testosterone. Without LH, natural testosterone …